Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers During Infection

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2017 Sep 29

PMID 28954888

Citations 66

Authors

Charlotte Odendall

Andrew A Voak

Jonathan C Kagan

Affiliations

Soon will be listed here.

Abstract

Type III IFNs (IFN-λs) are secreted factors that are well-known for their antiviral activities. However, their regulation and functions during bacterial infections are unclear. In this article, we report that the regulation of IFN-λ genes did not track with mechanisms that control type I IFN expression in response to TLRs. Whereas type I IFNs were only expressed from TLRs present on endosomes, type III IFNs could be induced by TLRs that reside at the plasma membrane and that detect various bacterial products. The mechanisms that regulate type III IFN gene expression tracked with those that promote inflammatory cytokine and chemokine expression. Importantly, rIFN-λs enhanced epithelial barriers in vitro, preventing transcellular bacteria dissemination. We therefore propose that in addition to their functions in cell-intrinsic antiviral immunity, type III IFNs protect epithelial barrier integrity, an activity that would benefit the host during any infectious encounter.

Citing Articles

Gut Barrier Dysfunction and Microbiota Variations in Cryptosporidiosis: A Comprehensive Review.

Ali M, Xu C, Wang M, Hina Q, Ji Y, Anwar S Vet Sci. 2025; 12(2).

PMID: 40005845 PMC: 11861801. DOI: 10.3390/vetsci12020085.

Toll-like receptor signaling in teleosts.

Su J Sci China Life Sci. 2025; .

PMID: 39961973 DOI: 10.1007/s11427-024-2822-5.

Interferon regulatory factor 7 alleviates the experimental colitis through enhancing IL-28A-mediated intestinal epithelial integrity.

Qing F, Tian H, Wang B, Xie B, Sui L, Xie X J Transl Med. 2024; 22(1):905.

PMID: 39370517 PMC: 11457333. DOI: 10.1186/s12967-024-05673-y.

Typhimurium infection inhibits macrophage IFNβ signaling in a TLR4-dependent manner.

Shuster M, Lyu Z, Augenstreich J, Mathur S, Ganesh A, Ling J Infect Immun. 2024; 92(10):e0009824.

PMID: 39269166 PMC: 11475681. DOI: 10.1128/iai.00098-24.

Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection.

Antos D, Parks O, Duray A, Abraham N, Michel J, Kupul S PLoS Pathog. 2024; 20(8):e1012498.

PMID: 39178311 PMC: 11376568. DOI: 10.1371/journal.ppat.1012498.

References

Lee S, Kim W, Moon S . Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells. Int J Mol Med. 2012; 30(4):945-52. DOI: 10.3892/ijmm.2012.1064. View

Odendall C, Dixit E, Stavru F, Bierne H, Franz K, Durbin A . Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol. 2014; 15(8):717-26. PMC: 4106986. DOI: 10.1038/ni.2915. View

Seth R, Sun L, Ea C, Chen Z . Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005; 122(5):669-82. DOI: 10.1016/j.cell.2005.08.012. View

Iwasaki A, Medzhitov R . Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004; 5(10):987-95. DOI: 10.1038/ni1112. View

Lin S, Lo Y, Wu H . Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature. 2010; 465(7300):885-90. PMC: 2888693. DOI: 10.1038/nature09121. View

Hallstrom K, McCormick B . Salmonella Interaction with and Passage through the Intestinal Mucosa: Through the Lens of the Organism. Front Microbiol. 2011; 2:88. PMC: 3128981. DOI: 10.3389/fmicb.2011.00088. View

Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, Namiki H . Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem. 2007; 282(10):7576-81. DOI: 10.1074/jbc.M608618200. View

Sommereyns C, Paul S, Staeheli P, Michiels T . IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 2008; 4(3):e1000017. PMC: 2265414. DOI: 10.1371/journal.ppat.1000017. View

Sun J, Li N, Oh K, Dutta B, Vayttaden S, Lin B . Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use. Sci Signal. 2016; 9(409):ra3. PMC: 5381726. DOI: 10.1126/scisignal.aab2191. View

10.

Kagan J, Magupalli V, Wu H . SMOCs: supramolecular organizing centres that control innate immunity. Nat Rev Immunol. 2014; 14(12):821-6. PMC: 4373346. DOI: 10.1038/nri3757. View

11.

Kotenko S, Gallagher G, Baurin V, Lewis-Antes A, Shen M, Shah N . IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2002; 4(1):69-77. DOI: 10.1038/ni875. View

12.

Brubaker S, Bonham K, Zanoni I, Kagan J . Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015; 33:257-90. PMC: 5146691. DOI: 10.1146/annurev-immunol-032414-112240. View

13.

Gay N, Gangloff M, ONeill L . What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol. 2011; 32(3):104-9. DOI: 10.1016/j.it.2010.12.005. View

14.

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H . Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003; 301(5633):640-3. DOI: 10.1126/science.1087262. View

15.

Nilsen N, Vladimer G, Stenvik J, Orning M, Zeid-Kilani M, Bugge M . A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling. J Biol Chem. 2014; 290(6):3209-22. PMC: 4318996. DOI: 10.1074/jbc.M114.593426. View

16.

Lebreton A, Lakisic G, Job V, Fritsch L, Tham T, Camejo A . A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response. Science. 2011; 331(6022):1319-21. DOI: 10.1126/science.1200120. View

17.

Mills D, Bajaj V, Lee C . A 40 kb chromosomal fragment encoding Salmonella typhimurium invasion genes is absent from the corresponding region of the Escherichia coli K-12 chromosome. Mol Microbiol. 1995; 15(4):749-59. DOI: 10.1111/j.1365-2958.1995.tb02382.x. View

18.

Rauch I, Rosebrock F, Hainzl E, Heider S, Majoros A, Wienerroither S . Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons. Mol Cell Biol. 2015; 35(13):2332-43. PMC: 4456449. DOI: 10.1128/MCB.01498-14. View

19.

Thomson S, Goh F, Banks H, Krausgruber T, Kotenko S, Foxwell B . The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11564-9. PMC: 2710658. DOI: 10.1073/pnas.0904477106. View

20.

Gay N, Symmons M, Gangloff M, Bryant C . Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol. 2014; 14(8):546-58. DOI: 10.1038/nri3713. View